Corrigendum to "Cost-Effectiveness of the Aerobika® Oscillating Positive Expiratory Pressure Device in the Management of Chronic Obstructive Pulmonary Disease Exacerbations in Canada"
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
[This corrects the article DOI: 10.1155/2019/9176504.].
References
1.
Thanh N, Jacobs P, Suggett J, McIvor A, Kaplan A
. Cost-Effectiveness of the Aerobika® Oscillating Positive Expiratory Pressure Device in the Management of Chronic Obstructive Pulmonary Disease Exacerbations in Canada. Can Respir J. 2019; 2019:9176504.
PMC: 6350564.
DOI: 10.1155/2019/9176504.
View